|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.00 EUR | -0.68% |
|
-2.67% | -30.48% |
| 05-15 | Collegium Pharmaceutical, Inc. Announces Appointment of Michael Donovan as Director | CI |
| 05-12 | Collegium completes acquisition of Azstarys® from Corium Therapeutics | RE |
Chart: Technical Analysis
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- COLL Stock
- 354 Stock
- Charts Collegium Pharmaceutical, Inc.
Select your edition
All financial news and data tailored to specific country editions
